Noninvasix, a health technology company, has six patents and a half dozen pending for technology to measure fetal welfare during labor and delivery and in premature babies. “In my business, patents are currency,” said CEO Graham Randall, who is in Dallas in a startup accelerator program.Read more on NewsOK.com